Phencyclidine (PCP) is a psychotomimetic agent that is extensively abused and whose intoxication is a major emergency room problem. The compound has no therapeutic indication in man and is manufactured and sold through illicit channels. As a result, the material is poorly quality controlled so that material sold as PCP can be material synthesized with alternate starting materials. Consequently, an array of phencyclidine derivatives have been sold as """"""""PCP"""""""". The object of this research is to establish the biochemistry of PCP metabolism in terms of pathways, enzymology, and mechanisms so that the changes in metabolism that may occur with structural changes can be predicted. In a more general sense, these questions are being addressed to many nitrogen containing compounds that are drugs of abuse. The study focuses on the metabolism of the heterocyclic ring of PCP because this pathway generates active metabolites and is the dominant pathway of metabolism in man. The objective is to be met in three specific aims: (1) to determine the biochemistry of phenylcyclohexylamine formation; (2) to determine the effect of heterocyclic ring size on metabolism; and (3) to examine heterocyclic ring metabolism in other drugs of abuse such as cocaine and fentanyl. The research utilizes in vitro and in vivo procedures with rats and rabbits, and GC, GCMS, and HPLC techniques for analysis. Stable isotope substituted variants are also used as probes in mechanistic studies.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
2R01DA002411-07
Application #
3207311
Study Section
(DABB)
Project Start
1979-08-01
Project End
1989-07-31
Budget Start
1985-08-01
Budget End
1986-07-31
Support Year
7
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Kuczenski, R; Segal, D S; Cho, A K et al. (1995) Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J Neurosci 15:1308-17
Hiratsuka, A; Chu, T Y; Distefano, E W et al. (1995) Inactivation of constitutive hepatic cytochromes P450 by phencyclidine in the rat. Drug Metab Dispos 23:201-6
Melega, W P; Williams, A E; Schmitz, D A et al. (1995) Pharmacokinetic and pharmacodynamic analysis of the actions of D-amphetamine and D-methamphetamine on the dopamine terminal. J Pharmacol Exp Ther 274:90-6
Pechnick, R N; Hiramatsu, M (1994) The effects of MK-801 on body temperature and behavior in the rat: cross-sensitization and cross-tolerance with phencyclidine. Eur J Pharmacol 252:35-42
Cho, A K; Hiramatsu, M; Kumagai, Y et al. (1993) Pharmacokinetic approaches to the study of drug action and toxicity. NIDA Res Monogr 136:213-25
Cho, A K; Hiramatsu, M; Schmitz, D A et al. (1993) A behavioral and pharmacokinetic study of the actions of phenylcyclohexyldiethylamine and its active metabolite, phenylcyclohexylethylamine. J Pharmacol Exp Ther 264:1401-5
Lin, L Y; Kumagai, Y; Cho, A K (1992) Enzymatic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomes. Chem Res Toxicol 5:401-6
Burstyn, J N; Iskandar, M; Brady, J F et al. (1991) Comparative studies of N-hydroxylation and N-demethylation by microsomal cytochrome P-450. Chem Res Toxicol 4:70-6
Cho, A K; Hiramatsu, M; Schmitz, D A et al. (1991) Pharmacokinetic and pharmacodynamic properties of some phencyclidine analogs in rats. Pharmacol Biochem Behav 39:947-53
Bejanian, M; Pechnick, R N; George, R (1990) Effects of acute and chronic administration of (+)-SKF 10,047 on body temperature in the rat: cross-sensitization with phencyclidine. J Pharmacol Exp Ther 253:1253-8

Showing the most recent 10 out of 17 publications